🇺🇸 FDA

Drug profile · INN

pentetate calcium trisodium yb-169

YTTERBIUM YB 169 DTPA

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

pentetate calcium trisodium yb-169 (YTTERBIUM YB 169 DTPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pentetate calcium trisodium yb-169
Brand YTTERBIUM YB 169 DTPA
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is pentetate calcium trisodium yb-169?

pentetate calcium trisodium yb-169 (YTTERBIUM YB 169 DTPA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pentetate calcium trisodium yb-169?

YTTERBIUM YB 169 DTPA is a marketed brand name for pentetate calcium trisodium yb-169. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pentetate calcium trisodium yb-169?

pentetate calcium trisodium yb-169 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.